Identification, molecular characterisation and antimicrobial susceptibility of genomovars of the Burkholderia cepacia complex in Spain

[1]  R. Hancock,et al.  In Vitro Susceptibility of Burkholderia vietnamiensis to Aminoglycosides , 2011, Antimicrobial Agents and Chemotherapy.

[2]  M. J. Pozuelo,et al.  Chronic colonization by Pseudomonas aeruginosa of patients with obstructive lung diseases: cystic fibrosis, bronchiectasis, and chronic obstructive pulmonary disease. , 2010, Diagnostic microbiology and infectious disease.

[3]  S. Oie,et al.  Microbiological safety of bottled mineral water in patients susceptible to infections. , 2008, Shokuhin eiseigaku zasshi. Journal of the Food Hygienic Society of Japan.

[4]  P. Vandamme,et al.  Burkholderia latens sp. nov., Burkholderia diffusa sp. nov., Burkholderia arboris sp. nov., Burkholderia seminalis sp. nov. and Burkholderia metallica sp. nov., novel species within the Burkholderia cepacia complex. , 2008, International journal of systematic and evolutionary microbiology.

[5]  C. Dowson,et al.  Burkholderia cepacia complex bacteria: opportunistic pathogens with important natural biology , 2008, Journal of applied microbiology.

[6]  M. Arduino,et al.  Multistate outbreak of Burkholderia cenocepacia colonization and infection associated with the use of intrinsically contaminated alcohol-free mouthwash. , 2007, Chest.

[7]  E. Álvarez-León,et al.  Intrinsically Contaminated Alcohol-Free Mouthwash Implicated in a Nosocomial Outbreak of Burkholderia cepacia Colonization and Infection , 2006, Infection Control & Hospital Epidemiology.

[8]  M. G. Chirillo,et al.  Burkholderia respiratory tract infections in Italian patients with cystic fibrosis: molecular characterization. , 2006, The Journal of infection.

[9]  A. Matlow,et al.  Sustained Endemicity of Burkholderia cepacia Complex in a Pediatric Institution, Associated With Contaminated Ultrasound Gel , 2006, Infection Control & Hospital Epidemiology.

[10]  R. Fontana,et al.  Molecular epidemiology and antibiotic susceptibility of Burkholderia cepacia-complex isolates from an Italian cystic fibrosis centre , 2006, European Journal of Clinical Microbiology and Infectious Diseases.

[11]  E. Guerrieri,et al.  Antibiotic resistance and antibacterial activity in heterotrophic bacteria of mineral water origin. , 2005, The Science of the total environment.

[12]  Joanna B. Goldberg,et al.  The multifarious, multireplicon Burkholderia cepacia complex , 2005, Nature Reviews Microbiology.

[13]  P. Vandamme,et al.  Characterizing uncommon Burkholderia cepacia complex isolates from an outbreak in a haemodialysis unit. , 2004, Journal of medical microbiology.

[14]  J. Elborn,et al.  Epidemiology of Burkholderia cepacia complex species recovered from cystic fibrosis patients: issues related to patient segregation. , 2004, Journal of medical microbiology.

[15]  P. Vandamme,et al.  Proposal to accommodate Burkholderia cepacia genomovar VI as Burkholderia dolosa sp. nov. , 2004, International journal of systematic and evolutionary microbiology.

[16]  W. Almawi,et al.  Outbreak of Burkholderia Cepacia Bacteremia Traced to Contaminated Hospital Water Used for Dilution of an Alcohol Skin Antiseptic , 2004, Infection Control & Hospital Epidemiology.

[17]  L. Saiman,et al.  Infection Control in Cystic Fibrosis , 2004, Clinical Microbiology Reviews.

[18]  P. Vandamme,et al.  Burkholderia cepacia complex genomovars: utilization of carbon sources, susceptibility to antimicrobial agents and growth on selective media , 2003, Journal of applied microbiology.

[19]  J. Lipuma,et al.  Burkholderia cepacia complex in cystic fibrosis: frequency of strain replacement during chronic infection. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  Tom Coenye,et al.  Burkholderia cenocepacia sp. nov.--a new twist to an old story. , 2003, Research in microbiology.

[21]  P. Vandamme,et al.  Evaluation of species-specific recA-based PCR tests for genomovar level identification within the Burkholderia cepacia complex. , 2002, Journal of medical microbiology.

[22]  P. Vandamme,et al.  Influence of taxonomic status on the in vitro antimicrobial susceptibility of the Burkholderia cepacia complex. , 2002, The Journal of antimicrobial chemotherapy.

[23]  P. Vandamme,et al.  Burkholderia anthina sp. nov. and Burkholderia pyrrocinia, two additional Burkholderia cepacia complex bacteria, may confound results of new molecular diagnostic tools. , 2002, FEMS immunology and medical microbiology.

[24]  P. Gilligan,et al.  Six-Year Molecular Analysis of Burkholderia cepacia Complex Isolates among Cystic Fibrosis Patients at a Referral Center for Lung Transplantation , 2002, Journal of Clinical Microbiology.

[25]  P. Vandamme,et al.  Burkholderia cepacia Complex Bacteria from Clinical and Environmental Sources in Italy: Genomovar Status and Distribution of Traits Related to Virulence and Transmissibility , 2002, Journal of Clinical Microbiology.

[26]  P. Vandamme,et al.  Burkholderia ambifaria sp. nov., a novel member of the Burkholderia cepacia complex including biocontrol and cystic fibrosis-related isolates. , 2001, International journal of systematic and evolutionary microbiology.

[27]  P. Vandamme,et al.  Burkholderia fungorum sp. nov. and Burkholderia caledonica sp. nov., two new species isolated from the environment, animals and human clinical samples. , 2001, International journal of systematic and evolutionary microbiology.

[28]  Didier Raoult,et al.  16S Ribosomal DNA Sequence Analysis of a Large Collection of Environmental and Clinical Unidentifiable Bacterial Isolates , 2000, Journal of Clinical Microbiology.

[29]  P. Vandamme,et al.  DNA-Based Diagnostic Approaches for Identification of Burkholderia cepacia Complex, Burkholderia vietnamiensis, Burkholderia multivorans,Burkholderia stabilis, and Burkholderia cepacia Genomovars I and III , 2000, Journal of Clinical Microbiology.

[30]  Richard B. Johnston,et al.  Chronic Granulomatous Disease: Report on a National Registry of 368 Patients , 2000, Medicine.

[31]  M. Kaufmann,et al.  Distribution of Genes Encoding Putative Transmissibility Factors among Epidemic and Nonepidemic Strains ofBurkholderia cepacia from Cystic Fibrosis Patients in the United Kingdom , 2000, Journal of Clinical Microbiology.

[32]  T. Ezaki,et al.  Burkholderia uboniae Sp. Nov., l‐Arabinose‐Assimilating but Different from Burkholderia thailandensis and Burkholderia vietnamiensis , 2000, Microbiology and immunology.

[33]  P. de Vos,et al.  Identification and Population Structure ofBurkholderia stabilis sp. nov. (formerly Burkholderia cepacia Genomovar IV) , 2000, Journal of Clinical Microbiology.

[34]  George Pickett,et al.  Superfluidity: A new twist to an old story , 2000, Nature.

[35]  P. Vandamme,et al.  Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov. , 1997, International journal of systematic bacteriology.

[36]  D H Persing,et al.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing , 1995, Journal of clinical microbiology.

[37]  T. Heulin,et al.  Polyphasic Taxonomy in the Genus Burkholderia Leading to an Emended Description of the Genus and Proposition of Burkholderia vietnamiensis sp. nov. for N2-Fixing Isolates from Rice in Vietnam , 1995 .

[38]  Henry D. Isenberg,et al.  Manual of Clinical Microbiology , 1991 .

[39]  S. Goodison,et al.  16S ribosomal DNA amplification for phylogenetic study , 1991, Journal of bacteriology.

[40]  P. Gilligan,et al.  Microbiology of airway disease in patients with cystic fibrosis , 1991, Clinical Microbiology Reviews.

[41]  Ellen Jo Baron,et al.  Manual of clinical microbiology , 1975 .

[42]  Lennart Sjöberg,et al.  Ahlstrand E , Persson L , Tidefelt U , Söderquist B. Alteration of the colonization pattern of coagulase-negative staphylococci in patients undergoing treatment for hematological malignancy. Eur J Clin Microbiol Infect Dis , 2011 .

[43]  B. Cournoyer,et al.  Epidemiology and molecular characterization of a clone of Burkholderia cenocepacia responsible for nosocomial pulmonary tract infections in a French intensive care unit. , 2010, Diagnostic microbiology and infectious disease.

[44]  S. Holland,et al.  Chronic granulomatous disease. , 2010, Inflammatory bowel diseases.

[45]  Adam Baldwin,et al.  Taxon K, a complex within the Burkholderia cepacia complex, comprises at least two novel species, Burkholderia contaminans sp. nov. and Burkholderia lata sp. nov. , 2009, International journal of systematic and evolutionary microbiology.

[46]  P. Vandamme,et al.  Burkholderia, Stenotrophomonas, Ralstonia, Brevundimonas, Comamonas, Delftia, Pandoraea, and Acidovorax , 2003 .

[47]  F. Baquero,et al.  Persistence and variability of Stenotrophomonas maltophilia in cystic fibrosis patients, Madrid, 1991-1998. , 2001, Emerging infectious diseases.